Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREVAIL: a Clinical Investigation on Providing Reduced Effects of Visible Alopecia Caused by Chemotherapy Using the Lily Device - a Safety and Efficacy Study.

NCT06786078 is registered in ClinicalTrials.gov with Luminate Medical, Inc. as lead sponsor.

NCT NCT06786078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06786078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREVAIL: a Clinical Investigation on Providing Reduced Effects of Visible Alopecia Caused by Chemotherapy Using the Lily Device - a Safety and Efficacy Study.
Lead sponsor
Luminate Medical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
December 20, 2024
Completion date
November 30, 2025
Enrollment
85 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced alopecia